253 related articles for article (PubMed ID: 20108380)
1. Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings.
Su CS; Chang WN; Huang SH; Lui CC; Pan TL; Lu CH; Chuang YC; Huang CR; Tsai NW; Hsieh MJ; Chang CC
Mov Disord; 2010 Mar; 25(4):452-8. PubMed ID: 20108380
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
4. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.
Kao PF; Wey SP; Yang AS
Kaohsiung J Med Sci; 2009 Nov; 25(11):601-7. PubMed ID: 19858039
[TBL] [Abstract][Full Text] [Related]
6. Cerebrotendinous xanthomatosis presenting with asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging.
Schotsmans K; De Cauwer H; Baets J; Ceyssens S; van den Hauwe L; Deconinck T; Helsen G
Acta Neurol Belg; 2012 Sep; 112(3):287-9. PubMed ID: 22527785
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
[TBL] [Abstract][Full Text] [Related]
10. Extrastriatal uptake related to dopaminergic dysfunction on
Hou PN; Huang YE; Chan SH
Hell J Nucl Med; 2023; 26(3):210-214. PubMed ID: 38085837
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
12. Study on retinal dopamine transporter in form deprivation myopia using the radiopharmaceutical tracer 99mTc-TRODAT-1.
Zhao J; Qu X; Qi Y; Zhou W; Liu X
Nucl Med Commun; 2010 Oct; 31(10):910-5. PubMed ID: 20700065
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopaminergic functioning in patients with sporadic and hereditary spastic paraplegias with parkinsonism.
Kim JS; Kim JM; Kim YK; Kim SE; Yun JY; Jeon BS
J Korean Med Sci; 2013 Nov; 28(11):1661-6. PubMed ID: 24265532
[TBL] [Abstract][Full Text] [Related]
14. Early white matter injuries associated with dopamine transporter dysfunction in patients with acute CO intoxication: A diffusion kurtosis imaging and Tc-99m TRODAT-1 SPECT study.
Chou MC; Lai PH; Li JY
Eur Radiol; 2019 Mar; 29(3):1375-1383. PubMed ID: 30143836
[TBL] [Abstract][Full Text] [Related]
15. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET.
Lai SC; Weng YH; Yen TC; Tsai CC; Chang HC; Wey SP; Ting G; Lu CS
Nucl Med Commun; 2004 Apr; 25(4):339-45. PubMed ID: 15097807
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Meegalla SK; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Kushner SA; McElgin WT; Mozley PD; Kung HF
J Med Chem; 1997 Jan; 40(1):9-17. PubMed ID: 9016323
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-sestamibi thigh SPECT/CT imaging for assessment of myopathy in cerebrotendinous xanthomatosis with histopathological and immunohistochemical correlation.
Chen SF; Chang CC; Huang SH; Lu CH; Chuang YC; Pan TL; Chang WN
Clin Nucl Med; 2014 Mar; 39(3):e202-7. PubMed ID: 23989447
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
19. Movement disorders in cerebrotendinous xanthomatosis.
Stelten BML; van de Warrenburg BPC; Wevers RA; Verrips A
Parkinsonism Relat Disord; 2019 Jan; 58():12-16. PubMed ID: 30054180
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
